Shonda Hawkins

Shonda Hawkins

Auto-generated profile, based on publicly available information

Shonda Hawkins

Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, MD, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
ATAjitha Thanabalasuriar
Ajitha Thanabalasuriar
ACAbby J. Chiang
Abby J. Chiang
CMChristopher Morehouse
Christopher Morehouse
MCMargarita Camara
Margarita Camara
SHShonda Hawkins
Shonda Hawkins
ADAntonio DiGiandomenico
Antonio DiGiandomenico
The underlying mechanisms contributing to injury-induced infection susceptibility remain poorly understood. Here, we describe a rapid increase in neutrophil cell numbers in the lungs following induction of thermal injury. These neutrophils expressed elevated levels of programmed death ligand 1 (PD-L1) and exhibited altered gene expression profiles indicative of a reparative population. Upon injury, neutrophils migrate from the bone marrow to the skin but transiently arrest in the lung vasculature. Arrested neutrophils interact with programmed cell death protein 1 (PD-1) on lung endothelial cells. A period of susceptibility to infection is linked to PD-L1+ neutrophil accumulation in the lung. Systemic treatment of injured animals with an anti–PD-L1 antibody prevented neutrophil accumulation in the lung and reduced susceptibility to infection but augmented skin healing, resulting in increased epidermal growth. This work provides evidence that injury promotes changes to neutrophils that are important for wound healing but contribute to infection susceptibility.